Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Cancer: 24-Month Results of the RSR1 Phase 1 Dose Escalation Study
Ariane Lapierre, Lionel Badet, Olivier Rouvière, G. Créhange, Julien Berthiller, P. Paparel, O. Chapet
Topics & Concepts
MedicineCommon Terminology Criteria for Adverse EventsToxicityRenal cell carcinomaRadiation therapyStereotactic radiation therapyNuclear medicineAblative caseLimitingTherapeutic indexRadiosurgeryUrologyOncologyInternal medicinePharmacologyMechanical engineeringEngineeringDrugRenal cell carcinoma treatmentMultiple and Secondary Primary CancersBrain Metastases and Treatment